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Abstract
This study investigated the effects of acute oral taurine ingestion on: (1) the power–time relationship using the 3-min all-out 
test (3MAOT); (2) time to exhaustion (TTE) 5% > critical power (CP) and (3) the estimated time to complete (Tlim) a range 
of fixed target intensities. Twelve males completed a baseline 3MAOT test on a cycle ergometer. Following this, a double-
blind, randomised cross-over design was followed, where participants were allocated to one of four conditions, separated 
by 72 h: TTE + taurine; TTE + placebo; 3MAOT + taurine; 3MAOT + placebo. Taurine was provided at 50 mg kg−1, whilst 
the placebo was 3 mg kg−1 maltodextrin. CP was higher (P < 0.05) in taurine (212 ± 36 W) than baseline (197 ± 40 W) and 
placebo (193 ± 35 W). Work end power was not affected by supplement (P > 0.05), yet TTE 5% > CP increased (P < 0.05) by 
1.7 min after taurine (17.7 min) compared to placebo (16.0 min) and there were higher (P < 0.001) estimated Tlim across all 
work targets. Acute supplementation of 50 mg kg−1 of taurine improved CP and estimated performance at a range of severe 
work intensities. Oral taurine can be taken prior to exercise to enhance endurance performance.
Keywords Critical power · Amino acids · Ergogenic aids
Introduction
The critical power (CP) demarcates the boundary between 
heavy and severe exercise domains (Jones et al. 2010). It 
represents the highest power output that can be maintained, 
without a continuous rise in oxygen uptake ( V̇O2 ) and blood 
lactate or reductions in intra-muscular phosphocreatine 
stores (Jones et al. 2008, 2010; Vanhatalo et al. 2016). Whilst 
the CP is typically measured over several days and bouts of 
constant load exercise, it has been shown that the finite work 
capacity above CP (W′) can be completely utilised in a single 
all-out, 3-min exercise test (3MAOT). This test permits 
reliable and valid calculation of an equivalent CP and a W′ 
value—the work end power (WEP) (Vanhatalo et al. 2007; 
Dekerle et al. 2006). Therefore, this single-visit test per-
mits quantification of work done above and below the CP; 
hence, the two-component model (Vanhatalo et al. 2007). 
Parameters of the power–time relationship can be used to 
describe a ‘gold standard’ demarcation of the metabolic 
steady state (CP; Jones et al. 2019) and the finite capacity 
of individuals > CP (W′), which can be used in combination 
to determine exercise performance (Jones et al. 2010; Jones 
and Vanhatalo 2017).
The CP provides a boundary that relates to both metabolic 
and respiratory control processes in the exercising human 
(Poole et al. 1988) and can be used to assess responses to 
training or acute dietary interventions, including caffeine 
(Machado et al. 2010; Cheng et al. 2016; Silveira et al. 2018), 
creatine (Smith et al. 1998; Miura et al. 1999; Vanhatalo and 
Jones 2009) and dietary nitrates (Kelly et al. 2013). Tau-
rine, a sulphur-containing amino acid, is the most abundant 
free amino acid in mammalian tissue (Huxtable 1992), and 
is available to facilitate a variety of biological processes 
that can support exercise performance. As reported with 
the above-mentioned acute dietary supplements, taurine 
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supplementation could theoretically alter components of the 
power–time relationship. For example, aerobically biased 
(endurance) exercise has typically been improved following 
taurine supplementation (see Waldron et al. 2018a; Souza 
et al. 2017 for reviews) and effects on skeletal muscle func-
tion have been reported (Dutka et al. 2014; Lim et al. 2018), 
which might collectively explain the improved exercise effi-
ciency following oral administration (Paulucio et al. 2017). 
These mechanistic actions relate to the factors ascribed to 
govern the balance of CP and W′, which include a loss of 
muscle efficiency, characterised by distinct metabolic (Jones 
et al. 2008; Vanhatalo et al. 2016) and neuromuscular (Burn-
ley et al. 2012) profiles.
The effects of taurine on performance have been some-
what mixed during high-intensity exercise (Milioni et al. 
2016; Warnock et al. 2017; Batitucci et al. 2018; Waldron 
et al. 2018b) and others have found no change in lower-
intensity steady-state performance or the physiological 
response to acute or chronic (7-day) taurine supplementa-
tion (1.66–3.32 g day−1) (Galloway et al. 2008; Rutherford 
et al. 2010). It is possible that inconsistency in the type of 
tests used, particularly during higher intensity exercise, 
have limited the current understanding. However, investi-
gating parameters of the power–time relationship using a 
test, such as the 3MAOT, provides capacity to quantify a 
‘gold standard’ marker of endurance exercise performance 
(Jones et al. 2019), which is tightly coupled to metabolic and 
cardiovascular control processes. Indeed, evaluation of the 
power–time relationship permits concomitant quantification 
of work capacity in severe-intensity domains (W′), which 
has not been determined following taurine supplementation. 
Understanding of the ways in which taurine supplementa-
tion might affect the two-component model would, therefore, 
reveal the domains of exercise that taurine supplementation 
is likely to enhance and extend the current understanding of 
its ergogenic role.
Therefore, this study investigated the effects of acute oral 
taurine ingestion on: (1) the power–time relationship using 
the 3MAOT; (2) time to exhaustion in the severe-intensity 
domain and (3) the estimated time to complete a range of 
fixed target intensities. It was hypothesised that oral taurine 
would alter the power–time relationship, thus increasing 
time to exhaustion at severe intensities.
Methods
Participants
Twelve recreationally active males (age 23 ± 3  years, 
stature 1.75 ± 0.61 m, body mass 75.5 ± 5.4 kg, V̇O2max 
54.9 ± 6.9 ml kg−1 min−1) took part in this study. Informed 
consent was obtained from all individual participants. A 
priori sample sizes were calculated using G*Power (Ver-
sion 3.0.10). Given the typical changes (Cohen’s d = 0.4; 
Waldron et al. 2018a) reported in endurance exercise after 
supplementation with taurine, a sample size of 12 was suf-
ficient to identify differences between groups with a statis-
tical power of 0.90. The participants were asked to arrive 
at the laboratory having not completed any exercise in the 
48 h before testing, having abstained from alcohol and caf-
feine consumption in the 24 h prior. The participants were 
instructed to stay hydrated and consume a well-balanced 
meal no less than 2 h before testing, which was recorded 
and replicated across each day using a personal food diary. 
None of the participants were taking any other drugs or 
forms of supplementation during the study period. The 
participants consumed an additional 200 ml of fluid 1 h 
prior to exercise during each visit. Institutional ethical 
approval was granted for this study, which was conducted 
in accordance with the 1964 Helsinki declaration.
Design
The participants reported to the laboratory on seven occa-
sions at the same time of day (10:00 am ± 1 h). On visit 
1, the participants were screened and performed an incre-
mental ramp test to measure maximal oxygen consumption 
( V̇O2max ) and determine the linear factor for the subsequent 
CP tests. On visit 2, a familiarisation session was pro-
vided, where the participants completed a critical power 
test at the pre-determined linear factor. On visit 3, the par-
ticipants completed their first experimental 3MAOT test 
on a cycle ergometer, which is hereafter referred to as the 
baseline CP. No supplement was provided at this visit. On 
visits 4–7, a double-blind, cross-over design was followed, 
whereby the participants completed either a 3MAOT or 
a time to exhaustion (TTE) at a fixed external power 
output 5% > the baseline CP. This meant that a TTE or 
3MAOT was conducted per visit with one of two supple-
ments (50 mg kg−1 taurine or 3 mg kg−1 maltodextrin pla-
cebo) randomly provided (TTE + taurine; TTE + placebo; 
3MAOT + taurine; 3MAOT + placebo). Participants were 
assigned to their conditions between visits 4 and 7 using 
block randomisation online software (Urbaniak and Plous 
2015). The dose of taurine was based on recent studies 
that have demonstrated its ergogenic effect (Waldron et al. 
2018a; Warnock et al. 2017) and was prepared by a labora-
tory technician, who was uninvolved with the experimental 
procedures. The supplement was not checked for purity 
and was provided as received from the manufacturer. Each 
visit was separated by no more than 72 h for each par-
ticipant, which was deemed sufficient to washout taurine 
based on half-life of between 0.7 and 1.4 h (Ghandforoush-
Sattari et al. 2010).
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Incremental ramp test
The participants performed an incremental exercise test on 
an electronically braked cycle ergometer (Lode Excalibur, 
Groningen, The Netherlands) to determine V̇O2max . After 
a 5-min, self-paced warm-up at an external workload of 
100 W, the test was started at approximately 160 W and 
increased by 25 W every minute until volitional fatigue. Res-
piratory gas exchange was measured breath-by-breath using 
a mask connected to a gas analysis system (Jaeger Oxycon 
Pro, Viasys Healthcare, Hoechberg, Germany). The gas 
analyzer and flow turbine were calibrated before each test 
using a known gas mixture (15%  O2 and 5%  CO2) and a 3-l 
syringe, respectively (Hans Rudolph, Kansas City, KS). The 
test was terminated when cadence fell 10 rev min−1 below 
the participants chosen cadence for more than 10 s, V̇O2max 
was determined as the highest mean value recorded over 30 s 
of the test. The ventilatory threshold (VT) was determined 
by two independent investigators using the V-slope method 
(Beaver et al. 1986).
Three‑minute all‑out test (3MAOT)
The 3MAOT was performed on the same cycle ergometer, 
which was adjusted to the participant based on their personal 
preferences recorded during the incremental test. The par-
ticipants performed a warm-up at 50 W of external power 
for 5 min, followed by 5 min of seated rest (no pedalling) 
on the ergometer. In the next stage, the participant cycled 
in isokinetic mode (unloaded) on the ergometer for 2 min 
and 50 s at a cadence of 90 rev min−1, followed by a 10-s 
period of 110 rev min−1. A countdown was given in the last 
5 s of the isokinetic phase to lead in to the 3MAOT, which 
was performed in linear mode. The participant’s linear factor 
was determined based on the mechanical power output 50% 
between VT and V̇O2max , which was achieved upon reaching 
their preferred cadence recorded during the incremental test 
(Vanhatalo et al. 2007) [linear factor = power (W)/cadence 
(rev min−1)2]. The participants were given non-specific ver-
bal encouragement throughout the test by the investigators, 
without feedback of time to avoid pacing. The test was fol-
lowed by 5-min recovery at 50 W. Peak power was deter-
mined as the highest external power maintained over a 1-s 
period. The end-power, hereafter referred to as the CP, was 
determined as the average external power sustained during 
the final 30 s of the test. The WEP was determined as the 
amount of external work (kJ) performed above the CP during 
the 3-min test. At the beginning (pre-warm-up) and 4 min 
after the end of the CP test, a capillary blood sample was 
collected from the finger to measure the change in blood 
lactate concentration (B[La] mmol l−1) using a calibrated 
analyser (Biosen C Line, EKF diagnostic GmbH, Barleben, 
Germany), with a coefficient of variation of 1.5%.
Time to exhaustion (TTE) 5% > critical power
After a 5-min warm-up at 100 W, a TTE was performed 
on the same ergometer at a power output 5% > the CP, as 
determined at the baseline visit. It was deemed appropri-
ate to use these values to demarcate the severe-intensity 
domain, as the participants were familiarised and the 
coefficient of variation for the 3MAOT end-power was 
commensurate with published literature between the famil-
iarisation and baseline visit (< 3.3% CV; Wright et al. 
2017). The CV% for TTE 5% > CP has been previously 
determined as 3.7% in our laboratory with recreationally 
active participants. The participants were told to maintain 
their preferred cadence for as long as possible at the given 
power output. Exhaustion was determined by a drop in 
cadence of 10 rev min−1 below the participants chosen rate 
for more than 10 s. Non-specific verbal encouragement 
was provided throughout all tests.
Estimation of target work
The CP and WEP values obtained in the 3MAOT were 
used to predict the time required to complete a series of 
work-done targets of: 50,100,150 and 200 kJ, using the 
following equation:
where Tlim is the limit of tolerance, W is the target work 
done (50–200 kJ), WEP and CP were the work end power 
(kJ) and critical power (W) determined from the respective 
tests. The chosen work-done targets were deemed to reflect 
the power–duration relationship within the severe-intensity 
domain (Jones et al. 2010).
Supplementation
All of the supplements were prepared in a powder form 
and measured using an analytical balance (Precisa 125A, 
Precisa Gravimetrics AG, Zurich, Switzerland) for sub-
sequent ingestion in gelatine capsules. The capsules con-
tained one of the following: taurine (50 mg kg−1 body 
mass) or placebo (3 mg kg−1 body mass maltodextrin). 
Participants’ body mass was taken prior to each trial to 
measure the correct dose and the supplements were bal-
anced such that an equal number of capsules were ingested 
between conditions. The dosages of taurine followed that 
recommended as safe, tolerable and ergogenic (Waldron 
et al. 2018a, c) and were all sourced from the same com-
pany (My Protein, Manchester, UK). After ingestion, the 
participants rested in a seated position for 1.5 h in a quiet 
room and were observed by the investigators. The 1.5-h 
timing was chosen as this permitted exercise to commence 
(1)Tlim = (W −WEP)∕CP,
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across the period of peak plasma availability of taurine 
after oral administration (Ghandforoush-Sattari et  al. 
2010).
Statistical analysis
A one-way repeated measures analysis of variance (ANOVA) 
was conducted to evaluate the effects of condition (baseline, 
taurine or placebo) on parameters of the power–time rela-
tionship (WEP, CP, peak power). A paired samples t test was 
used to assess the effects of condition (taurine or placebo) on 
the TTE at 5% > CP and the change in B[La] from pre–post-
test. A two-way repeated measures ANOVA was conducted 
to evaluate the effects of condition on the estimated time 
(Tlim) at various work-done targets (100–200 kJ). Green-
house–Geisser corrections were used when the assumption 
of sphericity was violated. Significant interactions were fol-
lowed up using Bonferroni tests to identify pairwise differ-
ences. Statistical significance was accepted at P < 0.05 and 
all analyses were performed on IBM SPSS Statistics (Ver-
sion 21, IBM Corp., Armonk, NY, USA).
Results
There were no trial order effects in the current study 
(P > 0.05). Post-study, the participants were asked to guess 
the order of supplements with respect to visits 4–7. The cor-
rect order of all four conditions was correctly guessed twice 
(16.7%), with two further participants correctly guessing 
three of four conditions (16.7%). The remainder of partici-
pants correctly guessed none (33.3%), one (8.3%) or two 
(25%) of the four conditions.
Three‑minute all‑out test (3MAOT)
During the 3MAOT, there was an effect of the supple-
ment on the CP [F(2,22) = 20.4, P < 0.001], with post hoc 
tests revealing differences between the taurine and base-
line (P = 0.001) or placebo (P = 0.003) conditions. Simi-
larly, peak power (F(2,22) = 8.2, P = 0.012) was highest in 
the taurine group, compared to baseline (P = 0.035) and 
placebo (F = 0.048) conditions. WEP was not affected by 
supplement, despite approaching significance [F(2,22) = 3.4, 
P = 0.079]. There were no differences (P > 0.05) between the 
baseline and placebo conditions for any measured variable 
(Fig. 1). The delta values for baseline–placebo, baseline–tau-
rine and placebo–taurine for critical power (− 4.2 ± 10.1 W; 
19.0 ± 13.3 W; − 14.8 ± 12.8 W, respectively), peak power 
(− 3.7 ± 21.2 W; − 65.4 ± 76.7 W; − 65.6 ± 71.1 W, respec-
tively) and WEP (− 0.5 ± 0.14 kJ; 2.1 ± 3.4 kJ; − 1.6 ± 3.4 kJ, 
respectively) are presented in Fig. 1b, d, f, respectively. Fig-
ure 2 shows this for a representative participant.
Exercise in the severe‑intensity domain
Time to exhaustion at 5% > CP was increased in the taurine 
condition compared to the placebo [t(11) = 4.4, P = 0.001]. 
A two-way ANOVA revealed further effects of taurine on 
Tlim [F(1,11) = 29.8, P < 0.001], which interacted with work 
targets [F(3,33) = 16.3, P = 0.002]. Post hoc tests demonstrated 
differences between taurine and placebo conditions across 
all work targets (P < 0.001) (Figs. 3, 4).
Blood lactate changes across the 3MAOT
There was an effect of the supplement on the change in 
B[La] from pre-to-post 3MAOT [F(2,22) = 5.9, P = 0.008], 
with differences between taurine and placebo (P = 0.007) 
but not baseline (P = 0.055) (Fig. 5).
Discussion
The primary aim of this paper was to investigate the 
effects of oral taurine supplementation on parameters 
of the power–time relationship during the 3MAOT. We 
found ~ 15 W increases in the CP compared to placebo 
but no significant change in the WEP, suggesting that the 
effects of taurine might be biased towards the oxidative 
component of the two-component CP bioenergetics model. 
However, the differences in WEP (2 kJ) approached signifi-
cance (P = 0.079) and contributed toward the consistently 
improved Tlim across a range of work targets. Indeed, the 
TTE, conducted at a power output 5% > baseline CP, was 
also significantly improved (1.7 min) and explained by the 
effects of taurine on the severe-intensity threshold. Collec-
tively, these findings are the first to show the contribution of 
taurine supplementation to exercise performed in the severe-
intensity domain, thereby highlighting the possible roles of 
taurine in muscle bioenergetics or cardiorespiratory control 
processes.
The increases in CP found here support the suggestions 
of recent meta-analyses, where the consumption of iso-
lated oral taurine (Waldron et al. 2018a), or as part of an 
energy drink (Souza et al. 2017), was reported to enhance 
endurance performance. Indeed, an increase of 15 W in the 
severe-intensity boundary could be significant for endurance 
athletes. However, the ergogenic effects of taurine were, 
perhaps, most effectively demonstrated via the improved 
TTE and estimated Tlim across a number of work targets 
(Figs. 3, 4). TIim across these fixed work targets is deter-
mined by a combination of the CP and WEP. Thus, changes 
in Tlim can be facilitated by both aerobically and anaero-
bically based metabolic control processes. For example, 
whilst exercise > CP is not entirely dependent on non-oxi-
dative energy pathways (Vanhatalo et al. 2010), inexorable 
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falls in muscle pH and concomitant depletion of PCr stores 
have been reported (Jones et al. 2008). As might be antici-
pated, exercise at these intensities is also associated with 
increased type II fibre recruitment in animal models (Copp 
et al. 2010). Taurine supplementation could logically assist 
with offsetting these sources of fatigue, particularly in rela-
tion to the enhanced severe-intensity exercise capacity and 
B[La] responses reported herein. Previous studies have high-
lighted the preferential action of taurine in the potentiation 
of the sarcoplasmic reticulum (SR) of type I and II muscle 
fibres, where it can improve force generation or attenuate 
fatigue-induced force losses (Bakker and Berg 2002; Ham-
ilton et al. 2006; Goodman et al. 2009; Dutka et al. 2014). 
Therefore, taurine supplementation could feasibly offset the 
decay of muscle force (particularly among glycolytic, fati-
gable fibres) observed during exercise testing. Furthermore, 
regulatory effects of taurine have been identified on voltage-
gated chloride (ClC-1) in striated rodent muscle cells (Conte 
et al. 1987). Thus, it is feasible that the effect on membrane 
stabilisation might also translate to the control of muscle 
Fig. 1  Critical power (a), ∆critical power (b), peak power (c), ∆peak power (d), work end power (e) and ∆work end power (f) during the 3-min 
all-out test in baseline, placebo or taurine conditions (n = 12). *Significantly different (P < 0.05) to comparison conditions
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function during acute fatigue, which is characterised by dys-
regulated membrane excitability (Fauler et al. 2012). Based 
on our findings, we contend that the inconsistent results in 
relation to taurine’s ergogenic capacity, to date, could be 
partly explained by the limited and variable modes of exer-
cise adopted. The dual effects of taurine on both W′ and 
CP appear to combine to enhance severe-intensity exercise 
capacity, when quantified using a valid and reliable, gold 
standard testing procedure. Further work is required to estab-
lish why severe-intensity exercise is augmented following 
taurine ingestion.
Whilst an abundant body of research supports the ergo-
genic role of taurine, there are a few studies that have 
reported trivial effects on performance (Rutherford et al. 
2010; Milioni et al. 2016; Ward et al. 2016). The closest 
of these to the current study (Milioni et al. 2016) reported 
‘unclear’ effects on the maximal accumulated oxygen deficit 
Fig. 2  Power–time relationship of a representative participant during 
the 3-min all-out test
Fig. 3  Time to exhaustion (a) and ∆time to exhaustion (b) at 5% > the critical power determined from the baseline 3-min all-out test in baseline, 
placebo or taurine conditions (n = 12). *Significantly different (P < 0.05) to comparison conditions
Fig. 4  Estimated time to complete (Tlim) target intensities of 100, 150, 
200 and 250  kJ in placebo or taurine conditions (n = 12). *Signifi-
cantly different (P < 0.001) to placebo
Fig. 5  Blood lactate concentration (B[La]) from pre-to-post critical 
power test in baseline, placebo or taurine conditions (n = 12). *Sig-
nificantly different (P < 0.01) to placebo and baseline delta (pre–post) 
values
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(MAOD), which is a measure of anaerobic capacity and a 
value that is reported to relate to the WEP (Hill and Smith 
1993, 1994). It is interesting to contrast these findings with 
the changes found here in the power–time relationship, 
since our results are perhaps more appropriately explained 
by the prevailing opinion that work done above the CP is 
not equivalent to the anaerobic capacity and more closely 
relates to a general exercise tolerance and delayed fatigue 
in the severe-intensity domain (Vanhatalo et al. 2010; Jones 
and Vanhatalo 2017). Indeed, the CP has been described 
as a ‘fatigue threshold’ (Poole et al. 2016), demarcating a 
boundary of tolerable exercise intensity. This interpretation 
is more in keeping with the ergogenic roles of taurine, which 
are commonly attributed to alterations in fuel utilisation 
(De Carvalho et al. 2018), improved mechanical efficiency 
(Paulucio et al. 2017) or efficiency of ATP turnover in the 
muscle cell (Hansen et al. 2010). Each of these mechanisms 
has potential to improve exercise tolerance across a range 
of intensities and could certainly support the 15-W change 
in CP. Further work to establish the capacity of taurine to 
affect skeletal muscle ion handling or metabolic processes 
in vivo is necessary.
In addition to its roles in skeletal muscle, taurine is active 
in smooth muscle and endothelial cells of the vasculature, 
acting directly on potassium channels (Abebe and Mozaffari 
2011), leading to improvements in vascular function (Sun 
et al. 2016). The CP is strongly related to the number of 
capillary contacts in both type I and II fibres of humans 
(Mitchell et al. 2018) and there is a dependency of the CP 
on muscle blood flow (Broxterman et al. 2015). Therefore, 
such mechanisms might have supported its increase after 
taurine supplementation. In the skeletal cells of mice, tau-
rine has also been shown to control the rate of glycolytic flux 
(Takahashi et al. 2016), thus inferring a direct role in the 
control of metabolic pathways that are known determinants 
of high-intensity performance—the perturbation of which 
might lead to premature fatigue (Poole et al. 1988). It is the 
combination of these effects that we propose as an explana-
tion for the concurrent improvements in both elements of 
the two-component model. Whilst a reciprocity between the 
CP and W′ is often reported as a result of dietary or train-
ing interventions (Jones and Vanhatalo 2017), supplements 
capable of participating in a variety of biological processes 
(i.e. cardiovascular, metabolic) are more likely to have com-
bined effects on the power–time relationship.
The effect of oral taurine on time-trial performance (as 
opposed to capacity testing) has also been inconsistent, 
which is surprising given the clear roles established herein. 
For example, Ward et al. (2016) reported no effects of tau-
rine on 4-km cycling time-trial performance, yet Balshaw 
et al. (2013) found improvements in 3-km time-trial run-
ning. The energetics of exercise across these distances 
relies heavily on capacity in the severe-intensity domain 
(Lacour et al. 1990) and, based on the current results, we 
would anticipate clear effects on closed-loop events of this 
distance. Indeed, the changes in severe-intensity exercise 
observed here (TTE and Tlim) are comparable or larger 
than those elicited by ischemic pre-conditioning (Griffin 
et al. 2018), beetroot juice (Kelly et al. 2013), beta ala-
nine (Black et al. 2018) and caffeine (Silveira et al. 2018). 
Therefore, the reason for the discrepancy in findings 
between individual studies is unclear, but could relate to 
the range of doses and supplementation periods used or the 
training status of the participants (Waldron et al. 2018a). 
The participants of the current study were recreationally 
active, with a history of competitive sport but were not 
currently competitively trained. This might also explain 
the magnitude of the change in performance, since mus-
cle taurine content is lower at baseline among untrained 
individuals (Graham et al. 1995). The type of research 
design has also varied between studies, with some includ-
ing an additional group who are told they are receiving 
taurine but do not (see Rutherford et al. 2010). This was 
not included in the current study, but might have ensured 
that the effects were not the result of placebo effects. 
Future research should be designed to directly address 
these problems.
From a practical perspective, the results of this study 
support others in demonstrating the ergogenic effect of 
taurine on exercise tolerance and infer that a single supple-
ment of taurine at a dose of 50 mg kg−1 body mass could 
improve performance across a range of exercise intensi-
ties. Therefore, an adult weighing 70 kg would require a 
dose of 3.5 g 1.5–2 h before training or competition to 
achieve an ergogenic effect. There have been no adverse 
side-effects reported across studies using doses up to 6 g 
(Waldron et al. 2018c), inferring the safety and tolerability 
of this supplement. The effects of taurine on endurance 
performance are fairly well-established among recreational 
athletes but, to date, there has been no work carried out 
on elite-level athletes, which is necessary to develop an 
understanding of the scope of taurine’s ergogenic effects.
Conclusion
Acute supplementation of 50 mg kg−1 of taurine increased 
exercise tolerance within the severe-intensity domain 
among recreationally active participants. The increase in 
CP supports the reported roles of taurine on the oxida-
tive energy system and, in combination with 2 kJ changes 
in WEP, estimated performance would be expected to 
improve at a range of severe intensities.
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